Anduril
AllocationsX price
140.92 USD
+134.87% all time
Last match
215.00
Sep 22, 2026
Highest bid
215.00
Lowest ask
—
Implied market cap
—
Live supply
—
Live demand
9M
Matches
0
All time
Anduril price
$79.20
Sep 25, 2025
The AllocationsX price is a per-security model indicative price estimate. It is calculated daily using a time-decayed, volume-weighted blend of confirmed transactions and bid/ask indications on the platform, weighted to favor recent, higher-volume activity. It is not a quote and does not represent an executable price.
About Anduril
Anduril — Autonomous defense systems and mission software. Anduril works with institutional and accredited investors to build category-defining products in the private markets.
- Founded
- 2015
- Employees
- 501-1000
- Headquarters
- New York, New York
- Website
- anduril.com
Market depth
LivePrice per share
For illustrative purposes only. Depth reflects the estimated cumulative dollar value of open buy indications currently posted on AllocationsX, including non-confirmed open orders.
Anduril transaction data
Detailed transaction data from the past year. Each row includes price per share, transaction size, share and transfer type, and status.
| Date | Share type | Transfer type | Status | ROFR | Price per share | Size |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Preferred | Forward | In progress | — | $115.55 | $5M-$20M |
| Aug 14, 2026 | Options | Direct | Closed | Waived | $124.01 | $1M-$5M |
Showing 2 of 2 transactions
Funding history
Anduril has raised across 4 identified funding rounds.
| Date | Class | Total raised | Valuation | PPE | Investors |
|---|---|---|---|---|---|
| May 2026 | Series H | $5B | $61B | — | Andreessen Horowitz, Thrive Capital |
| June 2025 | Series G | $2.5B | $30.5B | — | Founders Fund |
| August 2024 | Series F | $1.5B | $14B | — | Founders Fund, Sands Capital, Baillie Gifford, Counterpoint Global |
| December 2022 | Series E | $1.5B | $8.5B | — | Valor Equity Partners, Andreessen Horowitz, General Catalyst |
Data provided for informational purposes only and should not be the basis of an investment decision. AllocationsX has not verified this data as accurate or up to date.